<DOC>
	<DOCNO>NCT01376128</DOCNO>
	<brief_summary>The objective survey retrospectively collect evaluate information efficacy safety PAXIL tablet ( `` PAXIL '' , hereinafter ) pediatric subject ( age 18 ) panic disorder condition actual use .</brief_summary>
	<brief_title>Special Drug Use Investigation PAXIL Tablet ( Pediatric Panic Disorder )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Panic Disorder</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>Aged 18 time panic disorder diagnosis Aged 18 start day PAXIL treatment Having make periodic visit hospital receive treatment panic disorder Subjects treat paroxetine prior investigation Subjects hypersensitivity paroxetine Subjects take monoamine oxidase inhibitor ( MAOIs ) within 2 week stop treatment MAOIs Concomitant use patient take pimozide</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>